Ratings Summary for TORADOL

Overall Patient opinion of TORADOL: 2.9 (somewhat satisfied)

(based on 371 reviews ) (updated May 6, 2025)

Ratings by Age Group for TORADOL
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group	Number of Reviews	Average Rating
Pediatric (Under 18)	10	3.3
Age 18 to 24	39	2.7
Age 25 to 34	81	2.7
Age 35 to 44	97	3.0
Age 45 to 54	74	3.0
Age 55 to 64	48	2.8
Age 65 to 74	11	3.5
Age 75 and up	1	1

Ratings by Sex for TORADOL
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex	Number of Reviews	Average Rating
Male	64	2.984375
Female	297	2.91919191919192
Not Specified	10	2.7

Would you like to find reviews for TORADOL taken for a specific reason or resulting in a specific side effect?

Filter Results for TORADOL

Patient Type:	Any Male Female
Reason(s):
Side Effect(s):
Satisfaction:	1 2 3 4 5

FDA Drug Safety Information for TORADOL

Check here for Ask a Patient's Adverse Event Summary for TORADOL based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.

TORADOL (KETOROLAC TROMETHAMINE): Ketorolac is used for the short-term treatment (up to 5 days) of moderate to severe pain in adults, such as after surgery. Reducing pain helps you recover more comfortably so you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug (NSAID). It works by decreasing inflammation, swelling, and pain. FDA Approval Date: 1991-12-20 (Sources: U.S. Centers for Medicare Services, FDA)